Your browser doesn't support javascript.
loading
Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose.
Kessel, Aharon; Bamberger, Ellen; Nachshon, Liat; Rosman, Yossi; Confino-Cohen, Ronit; Elizur, Arnon.
Afiliação
  • Kessel A; Division of Allergy & Clinical Immunology, Bnai Zion Medical Center, Haifa, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Bamberger E; Division of Allergy & Clinical Immunology, Bnai Zion Medical Center, Haifa, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Nachshon L; Institute of Allergy, Immunology and Pediatric Pulmonology, Yitzhak Shamir Medical Center, Zerifin, Israel.
  • Rosman Y; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Confino-Cohen R; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Elizur A; Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel.
Allergy ; 76(11): 3538-3540, 2021 11.
Article em En | MEDLINE | ID: mdl-34370884
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel